Visualase
Device MRI-guided laser ablation
PDI 00643169792890
General payments
$765,513
Research payments
$3,672,196
Through program year 2025, $765,513 in general payments and $3,672,196 in research payments were reported against Visualase (MRI-guided laser ablation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $188,408 | 766 |
| 2025 | Research | $1,000 | 1 |
| 2024 | General | $201,178 | 358 |
| 2024 | Research | $342,846 | 47 |
| 2023 | General | $101,178 | 193 |
| 2023 | Research | $554,512 | 113 |
| 2022 | General | $88,606 | 299 |
| 2022 | Research | $1,414,501 | 182 |
| 2021 | General | $186,143 | 58 |
| 2021 | Research | $1,359,336 | 230 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,674 general · 573 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.